Fair Value Calculator Fair Value Calculator
EN DE

0862 (0862) Fair Value & Analysis

Industrials · Market cap HK$491M

0 0862 0862 · HK
PriceHK$1.25
Fair ValueHK$0.2400
Upside-80.8%
Quality53/100
Evidence: Low Range HK$0.1800 – HK$0.3600

Fair value as of: Jul 2, 2026

From 2 valuation models · updated today

Share price +150.0% over the past month.

Price vs Fair Value (12 months)

HK$1.75 HK$0.3200 Fair Value HK$0.2400 Jun 2025 Jun 2026

12‑month range HK$0.3200 – HK$1.75 · fair‑value band HK$0.1800 – HK$0.3600 · the HK$1.25 price screens above the HK$0.2400 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0862 (0862) currently trades at HK$1.25, while our model-based Fair Value estimate is HK$0.2400 — implying the stock looks roughly 80.8% overvalued today. We read business quality at 53/100 (solid quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, 0862 generated revenue of HK$360M at a net margin of -15.1%. Revenue declined 13.8% year over year. It earns a return on equity of -19.0%. Net debt stands at HK$140M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$360M
Revenue growth (YoY) -13.8%
Net margin -15.1%
Return on equity -19.0%
Free cash flow −HK$40.5M FY2025
Operating margin 4.0%
More key figures
EPS (TTM) HK$-0.0100
Net debt HK$140M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

0862 reported revenue of HK$390M in FY2025 versus HK$55.1M in FY2021, a compound +63.1%/yr. Reported net income was −HK$56.2M in FY2025.

Revenue +63.1%/yr
FY21 HK$55.1M
FY22 HK$127M
FY23 HK$401M
FY24 HK$525M
FY25 HK$390M
Net income
FY21 −HK$49.1M
FY22 −HK$32.2M
FY23 −HK$10.0M
FY24 −HK$56.5M
FY25 −HK$56.2M

Is 0862 fairly valued? → Check now

Similar stocks

6 more Conglomerates stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock Price Fair Value vs Fair Value
Honeywell International Inc HON C$25.91 C$14.79 -43%
Hitachi, Ltd HTHIY $30.12 $23.57 -22%
CITIC Limited 0267 HK$12.87 HK$21.98 +71%
0019 0019 HK$81.70 HK$13.77 -83%
CK Hutchison Holdings 0001 HK$68.50 HK$141.53 +107%
SK Inc 034730 579,000 KRW 370,641 KRW -36%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is 0862 (0862) undervalued?
As of Jul 2, 2026, our model estimates a fair value of HK$0.2400 versus a price of HK$1.25 — about −81% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 0862?
Our model-based fair value for 0862 is HK$0.2400 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$1.25.
What is the quality score of 0862?
0862 has a Quality Score of 53/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of 0862 (0862)?
0862 reported trailing-twelve-month revenue of about HK$360M (latest available figure, as of Jul 2, 2026).
What is the net profit margin of 0862?
The net profit margin of 0862 is about -15.1%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.